Skip to main content

Table 1 Patients’ characteristics at admission

From: Early and dynamic changes in gene expression in septic shock patients: a genome-wide approach

  SAPSII-lown = 14 (%) SAPSII-highn = 14 (%) pvalue Totaln = 28 (%)
Female n (%) 4 (28.57) 5 (35.72) ns 9 (32.1)
Male n (%) 10 (71.43) 9 (64.28) ns 19 (67.9)
Age median (Q1-Q3) 59 (46-69) 74 (58-79) ns 62 (54-76)
Non-survivor in 28 days n (%) 1 (7) 4 (28.5) ns 5 (17.9)
Charlson median (Q1-Q3) 2 (0-2.8) 2.5 (1.3-3.8) ns 2 (0.75-3.25)
SAPSII on admission median (Q1-Q3) 34 (29-40) 56 (49-63) <0.0001 45 (34-56)
Duration length in ICU median (Q1-Q3) 10 (5-11) 11 (6-30) ns 10 (5-14)
SOFA H6 11 (9-13) 10 (9-13) ns 10 (9-13)
Comorbidity n (%)    ns  
 0 9 (64.3) 7 (50)   16 (57.1)
 1 4 (28.6) 5 (35.7)   9 (32.1)
 >2 1 (7.1) 2 (14.3)   3 (10.7)
Type of admission n (%)    ns  
 Surgery 5 (35.7) 8 (57.1)   13 (46.4)
 Medical 9 (64.3) 6 (42.9)   15 (53.6)
Type of infection n (%)    ns  
 Community acquired 6 (42.86) 9 (64.29)   15 (53.5)
 Hospital acquired 8 (57.14) 5 (35.71)   13 (46.4)
Suspected infection n (%)     
 Clinically documented diagnosis 1 (7) 3 (21.4)   4 (16.6)
 Microbiologically documented diagnosis 13 (93) 11 (79)   24 (86)
  Bacilli Gram (−) 10 (77) 7 (64) ns 17 (61)
  Cocci Gram (+) 5 (38) 7 (64) ns 12 (43)
  Fungi 2 (15) 0   2 (7)
Cell count     
 White blood cells (giga/L) 13.16 (7.52-16.93) 6.97 (3.23-15.68) ns 11.07 (5.9-16.3)
 Lymphocytes 0.73 (0.32-1.22) 0.68 (0.4-1.33) ns 0.72 (0.35-1.3)
 Polymorphonuclear cells 10.14 (6.6-14.31) 5.45 (2.5-12.61) ns 9.56 (4.21-13.12)
 Monocytes 0.57 (0.49-1.66) 0.45 (0.19-0.66) ns 0.55 (0.38-0.67)
  1. ns, not significant. Significance was designated at the p < 0.05 level of confidence. Values represent effectives and percentage indicated in parentheses or median and first and third quartile indicated in parentheses.